Steve Kitchen, PhD

Lead Scientist
Sheffield Haemophilia and Thrombosis Centre

Steve Kitchen PhD Lead Clinical Scientist , Dept of Coagulation, Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals. Centre is designated an International Haemophilia Training Centre by World Federation of Haemophilia


Scientific Director, UK National External Quality Assessment Scheme for Blood Coagulation

Director WFH International External Quality Assessment Schemes for Blood Coagulation

Vice president Haemostasis, International Council for Standardisation in Haematology.

Presentation(s):

• OC 17.6 - Novel Developments in Diagnostics

  Sunday, July 10, 2022
  10:45 AM – 12:00 PM

• OC 17.2 - The measurement of a next-generation FVIII Mimetic, Mim8, using tissue factor triggered calibrated automated thrombography

  Sunday, July 10, 2022
  11:00 AM – 11:15 AM

• OC 17.5 - Direct Oral Anti-Coagulant (DOAC) external quality assessment (EQA) scheme assay results and interpretations from UKNEQAS BC DOAC Survey 19 2021.

  Sunday, July 10, 2022
  11:45 AM – 12:00 PM

• PT 03.2 - Panel discussion - MRX PT DOAC clinical utility

  Sunday, July 10, 2022
  12:30 PM – 1:00 PM

• PB0308 - Method Discrepant ADAMTS-13 activity results in first presentation query TTP subjects

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PT 11.1 - Opening

  Tuesday, July 12, 2022
  12:15 PM – 12:20 PM

• PT 11.3 - Introduction of the next presentation

  Tuesday, July 12, 2022
  12:35 PM – 12:40 PM

• PT 11.5 - Closing

  Tuesday, July 12, 2022
  12:55 PM – 1:00 PM

• PB1059 - Next-generation FVIII mimetic, Mim8, does not interfere with non-factor VIII haemostasis assays.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1060 - Multicentre Performance Evaluation and Reference Range for the Quantitative Determination of Factor IX Activity on the cobas t 711 Analyser

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1061 - Multicentre Performance Evaluation and Reference Range for an Immunoassay for the Quantitative Determination of Factor XIII Antigen on the cobas t 711 Analyser

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1070 - Whole Blood Impedance Aggregometry Is Inferior to Lumiaggregometry in the Diagnosis of Platelet Function Defects Amongst Women With Menorrhagia Referred for Surgical Intervention

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1075 - Discrepant results for ADAMTS13 assays with different activity assays. Artefact or cause for concern?

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1079 - Effect of anti -factor Xa direct oral anticoagulants (DOACs) on viscoelasticity measurements in External Quality Assessment (EQA) samples: UK NEQAS BC experience

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1100 - Vaccine Induced Immune Thrombocytopenia and Thrombosis (VITT) external quality assessment (EQA) scheme results and interpretations from a joint UKNEQAS BC, SSC and ECAT VITT Survey May 2021.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1101 - Measurement of fibrinogen using two concentrations of Thrombin with patients receiving Argatroban or normal plasma spiked with Argatroban: a review of UK NEQAS (Blood Coagulation) exercises 2021.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1306 - Evaluation of a LAMP assay for detection of Prothrombin Allele and Factor V Leiden

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM